- Increased [18F]FEPPA VT across examined brain regions in AN, notably ACC, ventral striatum, dorsal caudate and thalamus, ~52% mean elevation.
- ACC [18F]FEPPA VT correlated positively with eating concerns and rumination severity (EDE r=0.58; IDAS-II r=0.66).
- Findings indicate neuroinflammation and gliosis in AN with no significant association to BMI, suggesting gliosis-targeted interventions warrant study.
Biol Psychiatry. 2026 Nov 13:S0006-3223(26)01680-X. doi: 10.1016/j.biopsych.2026.11.003. Online ahead of print.
ABSTRACT
BACKGROUND: Inflammatory stimuli are associated with onset of anorexia nervosa (AN) but whether inflammation occurs in the brain of AN is unknown. The primary objective is to determine whether [18F]FEPPA total distribution volume ([18F]FEPPA VT), PET index of translocator protein density and inflammatory marker of gliosis, is elevated in AN in anterior cingulate cortex (ACC), ventral striatum (VS), dorsal caudate (DC), dorsal putamen (DP), thalamus, orbitofrontal cortex and insula. Secondary objectives are to determine the relationship of [18F]FEPPA VT in ACC to rumination severity and [18F]FEPPA VT to body mass index (BMI).
METHODS: [18F]FEPPA VT was measured in 20 medication free AN participants and 20 healthy controls. Correlations of [18F]FEPPA VT with rumination severity, and BMI, were determined.
RESULTS: [18F]FEPPA VT was elevated in AN in all ROI (linear mixed model (LMM), group effect, P = 4×10-7), particularly ACC, VS, DC and thalamus (mean 52% elevation; LMM, region by group interaction, P = 4×10-4). ACC [18F]FEPPA VT correlated positively with eating concerns (Eating Disorder Examination, r = 0.58, P = .007; Inventory of Depression and Anxiety Symptoms-II, r = 0.66, P = .002). There were no significant correlations between [18F]FEPPA VT and BMI.
CONCLUSIONS: Greater [18F]FEPPA VT is strong evidence for neuroinflammation and gliosis, particularly in ACC, VS, DC and thalamus in AN. Given such, it may be of interest to assess interventions that influence gliosis towards curative roles in future clinical trials in AN.
PMID:43025774 | DOI:10.1016/j.biopsych.2026.11.003
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

